AAPB White Paper
Generalized Anxiety Disorder
Paula Bram Amar, Ph.D.
Anxiety Disorders, according to the DSM-III-R, are the most frequently
observed category of emotional disorder in the American population. Anxiety is
understood to mean a chronic persistent sense of uneasiness or dread,
accompanied by distinct changes in physiology, and frequently accompanied by
avoidance behavior. Some anxiety is situation based or focused on particular
events or objects (phobia); other anxieties may focus on a particular set of
thoughts or actions (obsessions), or be rooted in a past event (post traumatic
stress). Panic tends to be more physiologically focused and may appear with or
without fear of public places (agoraphobia). The most common of the anxiety
disorders is Generalized Anxiety Disorder, although actual figures on its
prevalence are not available.
The essential feature of this disorder is pervasive tension or apprehension
with no distinguishable stressor. When anxious, the person experiencing the
anxiety shows many signs of physiologic arousal in the form of muscle tension,
autonomic hyperactivity, and vigilance and scanning.
The symptoms of muscle tension may include trembling, twitching or feeling
shaky. There may be feelings of muscle soreness, aches and pains, restlessness
and easy fatigability. Symptoms of autonomic hyperactivity may include shortness
of breath, palpitations, accelerated or irregular heart rate, sweating or cold
and clammy hands, dry mouth, dizziness, nausea, diarrhea, flushes or chills,
frequent urination, and trouble swallowing or a "lump in the throat". Symptoms
of vigilance and scanning may include feeling keyed up and on edge, exaggerated
startle response, difficulty concentrating or the mind going blank, difficulty
falling or staying asleep, and irritability.
Generalized Anxiety Disorder may occur in adults of any age,
children or adolescents but is most common in young adults. Treatment for
Generalized Anxiety Disorder most frequently combines modalities and may include
anti-anxiety medication. Behavioral treatment offers an alternative to such
medications, particularly for patients who do not respond well, or who have a
potential for dependency on medication. Biofeedback training is a part of the
behavioral treatment plan because it offers a non-pharmacologic approach to
direct symptom reduction and can be used in a manner specific to the individual
patient's psychophysiologic profile. For example, those patients experiencing
symptoms of muscle tension would be treated with EMG (electromyographic)
biofeedback to reduce their muscle tension. Those individuals whose symptoms are
autonomic would most often receive thermal (peripheral temperature) or heart
rate training. An EEG or a skin conductance (EDR or GSR) component may be added,
if assessment documents dysregulation in these areas. Biofeedback training is
generally preceded by a variety of relaxation training exercises.
Behavioral treatment may also include cognitive interventions
identify negative thinking, and to develop more appropriate assessment of life
events. Where specific fears can be identified, behavioral fear reduction
techniques such as desensitization, modeling, or flooding may be utilized.
Most studies document improvement and significant symptom reduction in 6 to
12 sessions, with more complex or chronic patients requiring a longer treatment
process. Like most behavioral treatments, biofeedback is most effective with
patients who are willing to take an active role in the treatment process.
In summary, Generalized Anxiety Disorder (GAD) refers to a
pervasive tension or apprehension which often interferes' with the quality of
everyday life. Because GAD is often marked by specific physiological
dysregulation, biofeedback is often considered one part of the multi-modal
behavioral treatment approach. Such an approach is generally brief, cost
effective, and avoids risk of dependency upon medication. It requires
willingness on the part of the patient to participate in the treatment process,
including compliance with home practice.
Barlow, D.H., Cohen, A.S., Waddell, M.T., Vermilyea, B.B., Klosko, J.S.,
Blanchard, E.B., & Di Nardo, P.A. (1984). Panic and generalized anxiety
disorders: Nature and treatment. Behavior Therapy, 15, 431-449.
Barlow, D.H., Blanchard, E.B., Vermilyea, J.A. (1986).Generalized anxiety and
generalized disorder:Prescription and reconceptualization. American Journal of Psychiatry, 143, 40-44.
Clark, M.E. & Hirschman, R. (1990). Effects of paced respiration on
anxiety reduction in a clinical population. Biofeedback and Self
Regulation, 15(3), 273-284.
Hardt, J.V. & Kamiya, J. (1978). Anxiety change through EEG-Alpha
feedback seen only in high anxiety subjects. Science, 201, 79-81.
Rice, K.M., Blanchard, E.B., & Purcell, M. (1993). Biofeedback treatments
of generalized anxiety disorder - preliminary results. Biofeedback and
Self-Regulation, 1a(2), 93-106.
|